211 related articles for article (PubMed ID: 15862960)
1. Regulation of aromatase and 5alpha-reductase by 25-hydroxyvitamin D(3), 1alpha,25-dihydroxyvitamin D(3), dexamethasone and progesterone in prostate cancer cells.
Lou YR; Murtola T; Tuohimaa P
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):151-7. PubMed ID: 15862960
[TBL] [Abstract][Full Text] [Related]
2. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.
Barreto AM; Schwartz GG; Woodruff R; Cramer SD
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):265-70. PubMed ID: 10750664
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1alpha,24-dihydroxyvitamin D2.
Bauer JA; Thompson TA; Church DR; Ariazi EA; Wilding G
Prostate; 2003 May; 55(3):159-67. PubMed ID: 12692781
[TBL] [Abstract][Full Text] [Related]
4. Mammary steroid metabolizing enzymes in relation to hyperplasia and tumorigenesis in the dog.
Marinelli L; Gabai G; Wolfswinkel J; Mol JA
J Steroid Biochem Mol Biol; 2004 Oct; 92(3):167-73. PubMed ID: 15555910
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells.
Golovko O; Nazarova N; Tuohimaa P
Life Sci; 2005 Jun; 77(5):562-77. PubMed ID: 15904673
[TBL] [Abstract][Full Text] [Related]
6. Nerve growth factor induces elevation of steroid 5alpha-reductase mRNA levels in rat C6 glioma cells through expression of transcription factor Egr-1.
Her S; Arimochi H; Morita K
Brain Res Mol Brain Res; 2004 Jul; 126(2):157-64. PubMed ID: 15249139
[TBL] [Abstract][Full Text] [Related]
7. Identification of VDR-responsive gene signatures in breast cancer cells.
Towsend K; Trevino V; Falciani F; Stewart PM; Hewison M; Campbell MJ
Oncology; 2006; 71(1-2):111-23. PubMed ID: 17377416
[TBL] [Abstract][Full Text] [Related]
8. Effects of 1,25(OH)2D3, 25OHD3, and EB1089 on cell growth and Vitamin D receptor mRNA and 1alpha-hydroxylase mRNA expression in primary cultures of the canine prostate.
Kunakornsawat S; Rosol TJ; Capen CC; Omdahl JL; Leroy BE; Inpanbutr N
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):409-12. PubMed ID: 15225811
[TBL] [Abstract][Full Text] [Related]
9. The synthetic estrogen diethylstilbestrol (DES) inhibits the telomerase activity and gene expression of prostate cancer cells.
Geier R; Adler S; Rashid G; Klein A
Prostate; 2010 Sep; 70(12):1307-12. PubMed ID: 20623632
[TBL] [Abstract][Full Text] [Related]
10. Regulation of HSD17B1 and SRD5A1 in lymphocytes.
Zhou Z; Speiser PW
Mol Genet Metab; 1999 Nov; 68(3):410-7. PubMed ID: 10562469
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT
Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of apolipoprotein D secretion by steroids coincides with inhibition of cell proliferation in human LNCaP prostate cancer cells.
Simard J; Veilleux R; de Launoit Y; Haagensen DE; Labrie F
Cancer Res; 1991 Aug; 51(16):4336-41. PubMed ID: 1868457
[TBL] [Abstract][Full Text] [Related]
13. Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells.
Stewart LV; Weigel NL
Prostate; 2005 Jun; 64(1):9-19. PubMed ID: 15651061
[TBL] [Abstract][Full Text] [Related]
14. Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays.
Krishnan AV; Shinghal R; Raghavachari N; Brooks JD; Peehl DM; Feldman D
Prostate; 2004 May; 59(3):243-51. PubMed ID: 15042599
[TBL] [Abstract][Full Text] [Related]
15. [Expression of type I and type II 5alpha-reductase isoenzymes in prostate cancer tissues].
Ye L; Zhang Y; Fang Z
Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1504-7. PubMed ID: 16200776
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of 5 alpha-reductase type 1 increases sensitivity of prostate cancer cells to low concentrations of testosterone.
Thomas LN; Douglas RC; Rittmaster RS; Too CK
Prostate; 2009 May; 69(6):595-602. PubMed ID: 19125422
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Egr-1 in HGF-induced elevation of the human 5alpha-R1 gene in human hepatocellular carcinoma cells.
Rui C; Li C; Xu W; Zhan Y; Li Y; Yang X
Biochem J; 2008 Apr; 411(2):379-86. PubMed ID: 18215136
[TBL] [Abstract][Full Text] [Related]
18. 5alpha-dihydrotestosterone inhibits 1alpha,25-dihydroxyvitamin D3-induced expression of CYP24 in human prostate cancer cells.
Lou YR; Nazarova N; Talonpoika R; Tuohimaa P
Prostate; 2005 May; 63(3):222-30. PubMed ID: 15538745
[TBL] [Abstract][Full Text] [Related]
19. Gene regulation profiles by progesterone and dexamethasone in human endometrial cancer Ishikawa H cells.
Davies S; Dai D; Pickett G; Leslie KK
Gynecol Oncol; 2006 Apr; 101(1):62-70. PubMed ID: 16289307
[TBL] [Abstract][Full Text] [Related]
20. The loss of 5alpha-reductase type I and type II mRNA expression in metastatic prostate cancer to bone and lymph node metastasis.
Habib FK; Ross M; Bayne CW; Bollina P; Grigor K; Chapman K
Clin Cancer Res; 2003 May; 9(5):1815-9. PubMed ID: 12738739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
